BioCentury
ARTICLE | Company News

Sequitur, PG functional genomics deal

October 9, 2001 7:00 AM UTC

Sequitur (Natick, Mass.) will conduct biological screens and supply antisense compounds to Procter and Gamble (PG) for use in target validation studies. Sequitur uses antisense compounds to determine ...